ArticleBlood2021
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia.
Ishwarya Murali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
46 papers cite it
this papertrialcites it
ArticleBlood2021
Ishwarya Murali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.